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(TAVI), the improvement of the results of the technique calls into question
this systematic approach. 
Purpose To evaluate feasibility and safety of TAVI performed without
ICU admission in patients considered at low risk according to simple clinical,
ECG, and echographic criteria. 
Methods Between December 2014 and May 2015, we included in a pro-
spective monocentric cohort study 99 consecutive patients undergoing TAVI.
Low risk group included patients with LVEF >40%, absence of severe pulmo-
nary disease, transfemoral (TF) access, stable hemodynamic state and absence
of complications occurring until 2 hours after the procedure. High risk group
included all other patients. Major in hospital cardiovascular adverse events
were recorded in the two groups (VARC-2 criteria). 
Results The study included 47 men (47.5%) and median age was 84 years
(79-88). Median Euroscore II was 4.1 (3.1-6.6). The balloon expandable
Sapien 3 valve was mainly used (79.6%; n=78), with TF approach and general
anesthesia for the majority of the patients (95.9% and 94.9%). A total 33
patients (33%) considered at low risk were admitted in the conventional car-
diology unit. At follow-up, only one low-risk patient (3.0%) developed a
minor complication (non compressive pericardial effusion with spontaneous
resolution) giving a NPV of the model of 97% (CI:0.84-1.0). Conversely, 21
patients (31.8%) from the high-risk group developed complications (PPV:
31.8%; CI: 0.21-0.44) (Table). 
Conclusion The results of our study suggest that TAVI procedure can be
performed safely without ICU admission in selected patients. This new “min-
imalist” strategy concerned one third of our patients but may probably be
extended considering the relatively low rate of events in the ICU admitted
group. 
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Background the association of severe aortic stenosis and mitral regurgita-
tion (MR) is not rare in patients undergoing transcatheter aortic valve implan-
tation (TAVI). The effect of TAVI on MR and its impact on outcome was
evaluated.
Methods All patients undergoing TAVI in our center were evaluated.
Patients with paravalvular leak or residual stenosis after TAVI were excluded.
Ninety out of 166 patients undergoing TAVI had follow-up data on post-pro-
cedural MR and constituted the patient population. Mitral regurgitation was
graded on a 0-4 scale and divided into two categories for survival analysis,
minimal (none/mild MR [grade 0-1/4]) and significant MR (moderate /severe
MR [grade 2-4/4]). Patients were followed for a median of 427 days for death
and development of heart failure (HF).
Results Average age was 81±6; 49% were male and the average Euroscore
was 22±15. Mitral regurgitation before TAVI was minimal in 52 pts (58%)
and significant in 38 pts (42%). Post TAVI, MR was minimal in 56 pts (62%)
and significant in 34 pts (38%). Sixteen pts (18%)developed worsening MR
with an increase of at least one MR grade post TAVI, 25 pts (28%) has an
improvement in the MR (MR grade was less) and 49 pts (54%) no change
occurred in the MR. Development of significant MR post successful TAVI
was a strong predictor of the development of HF (49±9% vs 70±6%, respec-
tively, p=0.02) as well as the combined end point of death and HF (event free
survival 46%±9% versus 64%±7%).
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Abstract 0352 – Figure: Histological analysis of the aortic valve
Abstract 0205 – Table: Cardiovascular adverse events in the two groups of patients
Post TAVI adverse events Low risk group (n=33) High risk group (n=66)
Death (n=1) 0 1 (1.5%)
New conductive disorder (n=17)
Permanent pacing requirement (n=14)
0
0
17 (17.2%)
14 (14,1%)
Major vascular complications (n=1) 0 1 (1.01%)
Pericardial effusion >10 mm
- cardiac tamponnade (n=2)
- non compressive (n=1)
 0
1 (3%)
 2 (2.02%)
0
TOTAL (n=22) 1 (3%) 21 (31.8%)
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Conclusions MR post TAVI without aortic regurgitation or residual ste-
nosis is a commmon issue and predicts the developemnt of HF and death.
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Background Pulmonary hypertension (PH) is one of the most powerful
predictors of outcome in patients with severe aortic stenosis (AS). However,
the mechanisms of PH occurring in the setting of AS are not fully under-
stood.
Methods We studied 60 consecutive AS patients referred for preoperative
assessment. Echocardiographic measurement: left ventricular ejection fraction
(LVEF), mass (iLVM), longitudinal systolic strain (LVS), mean aortic gra-
dient (MAG), aortic valve area (AVA), mitral E/A and E/e’ ratios, TAPSE,
tricuspid annulus S wave velocity, left atrial volume (iLAV), left atrial longi-
tudinal end systolic strain using speckle tracking (LAS). Right heart cathe-
terization (RHC) measurements: pulmonary artery pressures (s/d/mPAP),
pulmonary capillary wedge pressure (PCWP).
Results Patient age was 81±8 years. MAG was 45±16mmHg, AVA
0.74±0.2cm2, LVEF 63±16% (range 24-87), LVS –16±4%, LAS-4C 17±8%
and LAS-2C 18±9%. Intraobserver variability for LAS measurement was 6%,
interobserver variability was 7%. 
RHC showed: sPAP 51±18mmHg (range 28-101), mPAP 32±11mmHg
(range 15-60), PCWP 19±8mmHg. In univariate analysis, the following echo-
cardiographic parameters were associated with pulmonary artery pressures:
LVS, mitral E/A and E/e’ ratios, mitral E wave deceleration time, TAPSE, tri-
cuspid regurgitant flow velocity (feasibility 72%), LAS 4-C (feasibility
100%), and LAS 2-C (feasibility 94%). In multivariate analysis, except for the
tricuspid regurgitant velocity, only LAS was independently associated with
sPAP (r=–0.68, p<0.001). ROC analysis showed that a LA strain <13% pre-
dicted severe PH (sPAP >55mmHg) with a sensitivity of 85% and a speci-
ficity of 78%.
Conclusion LAS measured by speckle tracking analysis is a simple and
reproducible parameter and is a strong predictor of PH in patients with
severe AS. These results suggest the LA reservoir function is a critical
determinant of sPAP in AS. The prognostic value of LA strain should be
further assessed.
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A temporary pace-maker (TPM) is often used after TAVR due to the
risk of atrioventricular block (AVB) in the following days, related to pro-
gressive conduction system injuries. However guidelines are unclear as
when to safely remove it. Between 2013 and 2014, 195 patients without
previous permanent pacemaker, were prospectively followed after TAVR
(69 Edwards Sapiens (ES) and 126 CoreValve (CV)). 47 had preoperative
bundle branch block, 23 left (LBBB), 24 right sided (RBBB). Peri-opera-
tive high degree AVB was noted in 37 patients (20%). 24 were transient,
less than 10mn and; 13 persisted at the end of the procedure and were
implanted with a permanent pace-maker. New LBBB was observed in
55 patients (28%). In the post-operative period, 23 patients (13%) devel-
opped AVB (20 patients within 5 days, and 3 patients after 7 days) (4 ES
and 19 CV). No new AV block had occurred at one month in the
remaining population. Risk factors for late AVB were peri-operative tran-
sient AVB (40%), post-operative RBBB (30%), or LBBB (20%); preexis-
tent RBBB and Corevalve model. Conversely 41 of the 42 patients without
AVB or bundle branch block did not need temporary pacing in the post
operative time. The only patient without any perioperative event who
developed a late AV block at day 7 had a CV inserted in an old surgical
valve. However, sinus dysfunction occurred in 2 patients treated with
amiodarone for atrial fibrillation in the post operative period, needing tem-
porary pacing. Conclusion: The use of TPM after TAVR is common for
the management of delayed high degree AVB. The main risk factors are
peri-operative AVB and post-operative BBB. Most of delayed AVB occur
within 5 days. Later AVB preceded by prolonged PR interval and BBB
should increase the length of TPM. However, in the absence of these fac-
tors TPM could be shortened.
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Abstract 0304 – Figure: Time occurence of AVB (CV=Corevalve, ES=Sapien)
